Appendix II — T — Decisions Cited — T
Ninth Edition, Revision 01.2024
[ Editor Note: Opinions of the Patent Trial and Appeal Board or its predecessor organizations (Board) made available to the public after the Board first published Standard Operating Procedure 2 in 1994 (addressing the publication of Board opinions and the designation of such opinions as precedential) that (1) expressly indicate that the opinion is binding precedent of the Board or (2) are identified as binding precedent on the Board’s Precedential opinion website ( www.uspto.gov/patents-application-process/appealing -patent-decisions/decisions-and-opinions/precedential ) are precedential and binding authority. Prior to 1994, a decision by the Board was considered binding on panels of the Board only if the opinion was authorized by the Board to be published. See Ex parte Holt, 19 USPQ2d 1211 (Bd.Pat. App. & Int. 1991).]
Editor Note: When possible, parallel citations to the United States Reports or Federal Reporter and the United States Patent Quarterly (USPQ) are provided and include pinpoint pages, if appropriate. However, decisions of the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit published after July 11, 2022, no longer contain a pinpoint page for the USPQ citations.
Tabuchi v. Nubel, 559 F.2d 1183, 194 USPQ 521 (CCPA 1977) 2404.02
Takeda Chem. Indus., Ltd. v. Alphapharm Pty., Ltd., 492 F.3d 1350, 83 USPQ2d 1169 (Fed. Cir. 2007) 2143
Talbott, In re, 443 F.2d 1397, 170 USPQ 281 (CCPA 1971) 2135.01
Tanaka, In re, 640 F.3d 1246, 98 USPQ2d 1331 (Fed. Cir. 2011) 1402 , 1414
Tanczyn, In re, 347 F.2d 830, 146 USPQ 298 (CCPA 1965) 715.02
Tangsrud, In re, 184 USPQ 746 (Comm’r Pat. 1973) 214 , 215
Tansel, In re, 253 F.2d 241, 117 USPQ 188 (CCPA 1958) 2146.02
Tarczy-Hornoch, In re, 397 F.2d 856, 158 USPQ 141 (CCPA 1968) 2173.05(v)
Tas v. Beachy, 626 Fed. App'x. 999 (Fed. Cir. 2015) 2301.03 , 2304.02(c) , 2304.02(d)
Teague, In re, 254 F.2d 145, 117 USPQ 284 (CCPA 1958) 715.05 , 804.02
Technicon Instruments Corp. v. Alpkem Corp., 664 F. Supp 1558, 2 USPQ2d 1729 (D. Ore 1986) 2164.05(b)
Tech. Licensing Corp. v. Videotek, Inc., 545 F.3d 1316, 88 USPQ2d 1865 (Fed. Cir. 2008) 2181
Telcordia Techs., Inc. v. Cisco Systems, Inc., 612 F.3d 1365, 95 USPQ2d 1673 (Fed. Cir. 2010) 2181
Tennant Co. v. Hako Minuteman, Inc., 4 USPQ2d 1167 (N.D. Ill. 1987) 2293
Teva Pharms. Int’l GmbH v. Eli Lilly & Co., 8 F.4th 1349, 2021 USPQ2d 866 (Fed. Cir. 2021) 716.01(b)
Teva Pharmaceuticals USA, Inc v. Sandoz, Inc., 574 U.S. 318, 35 S. Ct. 831, 113 USPQ2d 1269 (2015) 2111.01 , 2131.01
Texas Instruments, Inc. v. Int’l Trade Comm’n, 988 F.2d 1165, 26 USPQ2d 1018 (Fed. Cir. 1993) 716.04
Thaler v. Vidal, 43 F.4th 1207 (Fed. Cir. 2022) 2109
Thales Visionix, Inc. v. United States, 850 F.3d 1343, 121 USPQ2d 1898 (Fed. Cir. 2017) 2106 , 2106.04(a) , 2106.05(a) , 2106.05(f)
Theis, In re, 610 F.2d 786, 204 USPQ 188 (CCPA 1979) 2133.03(b) , 2133.03(e)(1) , 2133.03(e)(3) , 2133.03(e)(6)
The NutraSweet Co., Ex parte, 19 USPQ2d 1586 (Bd. Pat. App. & Inter. 1991) 716.02(a)
Telefonaktiebolaget LM Ericsson v. TCL Corp., 941 F.3d 1341, 2019 USPQ2d 428076 (Fed. Cir. 2019) 2128.01
The Telephone Cases, 126 U.S. 1 (1888) 2106.05(f) , 2163
Theodor Groz & Sohne & Ernst Beckert Nadelfabrik KG v. Quigg, 10 USPQ2d 1787 (D.D.C. 1988) 2265 , 2272
Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276, 99 USPQ2d 1065 (Fed. Cir. 2011) 2000.01 , 2016 2803
Thomas & Betts Corp. v. Litton Sys., Inc., 720 F.2d 1572, 220 USPQ 1 (Fed. Cir. 1983) 2141.03
Thomas D. Sykes v. Jon W. Dudas, 573 F.Supp2d 191, 89 USPQ2d 1423 (D.D.C. 2008) 2710
Thompson, Ex parte, Appeal 2011-011620 (March 21, 2014) 716.04
Thomson, Ex parte, 24 USPQ2d 1618 (Bd. Pat. App. & Inter. 1992) 2121.03
Thorington, In re, 418 F.2d 528, 163 USPQ 644 (CCPA 1969) 804 , 1504.06
Thorner v. Sony Computer Entertainment America LLC, 669 F.3d 1362, 101 USPQ2d 1457 (Fed. Cir. 2012) 2111.01
Thorpe, In re, 777 F.2d 695, 227 USPQ 964 (Fed. Cir. 1985) 2113 , 2148
Thumm, Ex parte, 132 USPQ 66 (Bd. App. 1961) 716.02(a)
Tiffin, In re, 443 F.2d 394, 170 USPQ 88 (CCPA 1971) 716.04 , 2142
Tiffin, In re, 448 F.2d 791, 171 USPQ 294 (CCPA 1971) 716.03(a)
Tilghman v. Proctor, 102 U.S. 707 (1880) 2106.04(b) , 2106.05(c)
Tillotson Ltd. v. Walbro Corp., 831 F.2d 1033, 4 USPQ2d 1450 (Fed. Cir. 1987) 1412.03
Titanium Metals Corp. of America v. Banner, 778 F.2d 775, 227 USPQ 773 (Fed. Cir. 1985) 2112.01 , 2131.01 , 2131.03 , 2144.05
TLI Communications LLC v. AV Automotive LLC, 823 F.3d 607, 118 USPQ2d 1744 (Fed. Cir. 2016) 2106 , 2106.04(a) , 2106.04(a)(2) , 2106.05(a) , 2106.05(b) , 2106.05(d) , 2106.05(f)
Tol-O-Matic, Inc. v. Proma Produkt-Und Mktg. Gesellschaft m.b.H., 945 F.2d 1546, 20 USPQ2d 1332 (Fed. Cir. 1991) 2107.02
Tomlinson, In re, 363 F.2d 928, 150 USPQ 623 (CCPA 1966) 2112.02
Tone Brothers, Inc. v. Sysco Corp., 28 F.3d 1192, 31 USPQ2d 1321 (Fed. Cir. 1994) 1504.02 , 2133.03(e)(6)
Toro Co. v. Deere & Co., 355 F.3d 1313, 69 USPQ2d 1584 (Fed. Cir. 2004) 2112
Toro Co. v. White Consol. Indus., Inc., 199 F.3d 1295, 53 USPQ2d 1065 (Fed. Cir. 1999) 804 , 2111.01
TorPharm., Inc. v. Ranbaxy Pharmaceuticals, 336 F.3d 1322, 67 USPQ2d 1511 (Fed. Cir. 2003) 2116.01
Townsend v. Smith, 36 F.2d 292, 4 USPQ 269 (CCPA 1929) 2138.04
TP Labs., Inc. v. Professional Positioners, Inc., 724 F.2d 965, 220 USPQ 577 (Fed. Cir. 1984) 2133.03(a)
TQP Development, LLC v. Intuit Inc., 2014 WL 651935 (E.D. Tex. 2014) 2106.04(a)(2)
Trading Techs. Int'l, Inc. v. CQG, Inc., 675 Fed. App'x. 1001 (Fed. Cir. 2017) 2106.04(a)(1) , 2106.05(a)
Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994) 211.05 , 2107.01 , 2165.01
Translogic Technology Inc., In re, 504 F.3d 1249, 84 USPQ2d 1929 (Fed. Cir. 2007) 2114 , 2286
Transmatic, Inc. v. Gulton Indus., Inc., 601 F.2d 904, 202 USPQ 559 (6th Cir. 1979) 1504.06
Trans Texas Holdings Corp., In re, 498 F.3d 1290, 83 USPQ2d 1835 (Fed. Cir. 2007) 2259 , 2286
TransWeb v. 3M, 812 F.3d 1295, 117 USPQ2d 1617 (Fed. Cir. 2016) 2004
TriMed, Inc. v. Stryker Corp., 514 F.3d 1256, 85 USPQ2d 1787 (Fed. Cir. 2008) 2181
Trimless Cabinets, In re, 128 USPQ 95 (Comm’r Pat. 1960) 103
Tronzo v. Biomet, Inc., 156 F.3d 1154, 47 USPQ2d 1829 (Fed. Cir. 1998) 211.05 , 2163 , 2163.03 , 2163.05
Trs. of Bos. Univ. v. Everlight Elecs. Co., LTD., 896 F.3d 1357, 127 USPQ2d 1609 (Fed. Cir. 2018) 2161.01
Tucker, Ex parte, 1901 C.D. 140, 47 O.G. 187 (Comm’r Pat. 1901) 1503.02
Tucker v. Naito, 188 USPQ 260 (Bd. Pat. Inter. 1975) 2109
Tucker v. Natta, 171 USPQ 494 (Bd. Pat. Inter. 1971) 2138.06
Tucker Aluminum Prods. v. Grossman, 312 F.2d 393, 136 USPQ 244 (9th Cir. 1963) 2133.03(e)(1)
Tvngo Ltd. (BVI) v. LG Elecs. Inc., 861 Fed. Appx. 453, 2021 USPQ2d 697 (Fed. Cir. 2021) 2173.03
Twin Disc, Inc. v. United States, 231 USPQ 417 (Cl. Ct. 1986) 2131.05
Tyco Healthcare Grp. v. Ethicon EndoSurgery, Inc., 774 F.3d 968, 112 USPQ2d 1979 (Fed. Cir. 2014) 2138.06
Typhoon Touch Inc. v. Dell Inc., 659 F.3d 1376, 100 USPQ2d 1690 (Fed. Cir. 2011) 2181
Tytgat, Ex parte, 225 USPQ 907 (Bd. Pat. App. & Inter. 1985) 2308.03
Cited authority
- 2404.02 Biological Material That Can Be Made or Isolated Without Undue Experimentation
- 2143 Examples of Basic Requirements of a Prima Facie Case of Obviousness
- 2135.01 The Four Requirements of Pre-AIA 35 U.S.C. 102(d)
- 1402 Grounds for Filing
- 1414 Content of Reissue Oath/Declaration
- 715.02 How Much of the Claimed Invention Must Be Shown, Including the General Rule as to Generic Claims
- 214 Formal Requirements of Claim for Foreign Priority
- 215 Certified Copy of Foreign Application
- 2146.02 Establishing Common Ownership or Joint Research Agreement Under Pre-AIA 35 U.S.C. 103(c)
- 2173.05(v) Mere Function of Machine
- 2301.03 Interfering Subject Matter
- 2304.02(c) Explaining Priority
- 2304.02(d) Adequate Written Description
- 715.05 U.S. Patent or Application Publication Claiming Same Invention
- 804.02 Avoiding a Double Patenting Rejection
- 2164.05(b) Specification Must Be Enabling to Persons Skilled in the Art
- 2181 Identifying and Interpreting a 35 U.S.C. 112(f) or Pre-AIA 35 U.S.C. 112, Sixth Paragraph Limitation
- 2293 Intervening Rights
- 716.01(b) Nexus Requirement and Evidence of Nonobviousness
- 2111.01 Plain Meaning
- 2131.01 Multiple Reference 35 U.S.C. 102 Rejections
- 716.04 Long-Felt Need and Failure of Others
- 2109 Inventorship
- 2106 Patent Subject Matter Eligibility
- 2106.04(a) Abstract Ideas
- 2106.05(a) Improvements to the Functioning of a Computer or To Any Other Technology or Technical Field
- 2106.05(f) Mere Instructions To Apply An Exception
- 2133.03(b) “On Sale”
- 2133.03(e)(1) Commercial Exploitation
- 2133.03(e)(3) “Completeness” of the Invention
- 2133.03(e)(6) Permitted Experimental Activity and Testing
- 716.02(a) Evidence Must Show Unexpected Results
- 2128.01 Level of Public Accessibility Required
- 2163 Guidelines for the Examination of Patent Applications Under the 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, first paragraph, “Written Description” Requirement
- 2265 Extension of Time
- 2272 After Final Practice
- 2016 Fraud, Inequitable Conduct, or Violation of Duty of Disclosure Affects All Claims
- 2803 Persons Who May File a Request for Supplemental Examination
- 2141.03 Level of Ordinary Skill in the Art
- 2710 Term Extensions or Adjustments for Delays Within the USPTO Under 35 U.S.C. 154
- 2121.03 Plant Genetics — What Constitutes Enabling Prior Art
- 804 Definition of Double Patenting
- 1504.06 Double Patenting
- 2113 Product-by-Process Claims
- 2148 Form Paragraphs for Use in Rejections Under Pre-AIA 35 U.S.C. 103
- 2142 Legal Concept of Prima Facie Obviousness
- 716.03(a) Commercial Success Commensurate in Scope With Claimed Invention
- 2106.04(b) Laws of Nature, Natural Phenomena & Products of Nature
- 2106.05(c) Particular Transformation
- 1412.03 Broadening Reissue Claims
- 2112.01 Composition, Product, and Apparatus Claims
- 2131.03 Anticipation of Ranges
- 2144.05 Obviousness of Similar and Overlapping Ranges, Amounts, and Proportions
- 2106.04(a)(1) Examples of Claims That Do Not Recite Abstract Ideas
- 2106.05(b) Particular Machine
- 2106.05(d) Well-Understood, Routine, Conventional Activity
- 2107.02 Procedural Considerations Related to Rejections for Lack of Utility
- 2112.02 Process Claims
- 1504.02 Novelty
- 2112 Requirements of Rejection Based on Inherency; Burden of Proof
- 2116.01 Novel, Nonobvious Starting Material or End Product
- 2138.04 “Conception”
- 2133.03(a) “Public Use”
- 2106.04(a)(2) Abstract Idea Groupings
- 211.05 Sufficiency of Disclosure in Prior-Filed Application
- 2107.01 General Principles Governing Utility Rejections
- 2165.01 Considerations Relevant to Best Mode
- 2114 Apparatus and Article Claims — Functional Language
- 2286 Ex Parte Reexamination and Litigation Proceedings
- 2259 Res Judicata and Collateral Estoppel in Reexamination Proceedings
- 2004 Aids to Compliance With Duty of Disclosure
- 103 Right of Public To Inspect Patent Files and Some Application Files
- 2163.03 Typical Circumstances Where Adequate Written Description Issue Arises
- 2163.05 Changes to the Scope of Claims
- 2161.01 Computer Programming, Computer Implemented Inventions, and 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph
- 1503.02 Drawing
- 2138.06 “Reasonable Diligence”
- 2173.03 Correspondence Between Specification and Claims
- 2131.05 Nonanalogous or Disparaging Prior Art
- 2308.03 Estoppel Within the Office